Change of Name

Recorded: 2005-08-24 Received: 2005-08-24 Pages: 4

Assignor

RIBAPHARM INC.

Executed: 2005-04-05

Assignee

VALEANT RESEARCH & DEVELOPMENT

3300 HYLAND AVENUE, COSTA MESA, CA, 92626, UNITED STATES

Covered Properties (3)

Optical Bypass Method and Architecture

Application: 10/454,774 →

Inhibitors for De Novo-Rna Polymerases and Methods of Identifying Targets for Same

Application: 10/330,369 →

Nucleoside Compounds and Uses Thereof

Application: 10/318,476 →